Trial Profile
Micafungin Anti-Fungal Prophylaxis in Immunocompromised Pediatric Patients: A Pharmacokinetic Study
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 29 May 2018
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- 21 May 2018 Status changed from active, no longer recruiting to discontinued.
- 05 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 11 Mar 2014 New trial record